Introduction
The swine-origin pandemic A/H1N1 influenza virus caused a sizable epidemic in Mexico in winter 2011e2012 following a 2-year period of sporadic transmission. Mexico experienced a series of three A/H1N1 pandemic waves in the spring, summer, and fall of 2009 (1e3) followed by a large pandemic vaccination campaign towards the end of 2009. These three waves were together associated with a high excess mortality burden relative to that seen in other countries (4e6). Because a significant fraction of the population is now protected from A/H1N1 influenza through natural exposure or vaccination (7) , there is potential for the emergence of drift A/H1N1 influenza variants and/or changing age patterns as typically seen during post-pandemic periods (8, 9) .
Here we report on the epidemiology of a recrudescent (fourth) wave of pandemic A/H1N1 influenza activity in Mexico from December 1, 2011eMarch 20, 2012 and update our preliminary findings based on data up to February 10, 2012 (10) . Because past pandemic experiences have indicated substantial post-pandemic morbidity and mortality burden may occur months to years after the initial pandemic waves (9,11e14), we must remain vigilant and continue to monitor the virological characteristics of the 2009 A/H1N1 influenza virus (10,15e17) and compare the epidemiological characteristics of laboratory-confirmed A/H1N1 hospitalizations and deaths in winter 2011e2012 with those previously reported for the 2009 pandemic waves and show a significant change in the age distribution of cases and deaths.
Materials and Methods

Epidemiological Data
Individual level hospitalization data were available from a prospective epidemiological surveillance system that was put into place especially for the 2009 influenza pandemic by the Mexican Institute for Social Security (IMSS) (4, 18, 19) . IMSS is a tripartite Mexican health system covering approximately 40% of the Mexican population comprising workers in the private sector and their families, relying on a network of 1,099 primary healthcare units and 259 hospitals nationwide. The age and gender distributions of persons affiliated with the IMSS medical system are representative of the general Mexican population (4).
We analyzed information from all hospitalizations and in-patient deaths among patients admitted with severe acute respiratory infection (SARI) during December 1, 2011eMarch 20, 2012 . SARI was defined in a person with respiratory difficulty presenting fever 38 C and cough together with one or more of the following clinical symptoms: confinement to bed, thoracic pain, polypnea, or acute respiratory distress syndrome. Children !5 years of age with pneumonia or severe pneumonia that required hospitalization were also considered as SARI cases. Respiratory swabs were obtained for about 26% of SARI hospitalizations in winter 2011e2012 and were tested for the influenza virus by rRT-PCR (20) .
For all SARI hospitalizations, we retrieved demographic information (age in years and gender), influenza laboratory test result (if tested), reporting state (including 31 states plus the Federal District), and dates of symptom onset (self-reported). We also obtained population data by state and age group for all persons affiliated with the IMSS in 2009 to calculate incidence rates.
Age Distribution and Severity of A/H1N1 Influenza in 2009 and 2011e2012
We examined the age distribution of hospitalizations and deaths based on all cases of SARI and laboratoryconfirmed A/H1N1 influenza patients reported from December 1, 2011eMarch 20, 2012. We compared the age distribution of hospitalizations and deaths in winter 2011e2012 with those described for the three waves of the 2009e2010 A/H1N1 pandemic in Mexico 8 (April 1, 2009eMarch 31, 2010) using the same IMSS reporting system. We also calculated the in-hospital case fatality rate by dividing inpatient deaths by hospitalizations, separately for SARI and laboratory-confirmed A/H1N1. (21) . The early ascending phase was determined as the period between the day of pandemic onset and the midpoint between the onset and peak days. We assumed a mean generation interval of 3 and 4 days, which are within the range of mean estimates for the 2009 influenza pandemic (2,22e24). As a sensitivity analysis we also assessed small variations in the length of the ascending epidemic phase used to estimate the exponential growth rate (AE4 days).
Statistical analyses were performed using SPSS v.20.0 and Matlab (The Mathworks, Inc.).
Results
Overall Epidemiological Patterns
The characteristics of all SARI and A/H1N1-positive hospitalizations reported to the IMSS medical system between December 1, 2011 and March 20, 2012 are presented in Table 1 . The time series of daily SARI hospitalizations and deaths and laboratory-confirmed influenza hospitalizations are shown in Figures 1 and 2 
Severity of Disease
Age
Overall, the majority of laboratory-confirmed influenza inpatients during December 1, 2011eMarch 20, 2012 were among persons aged 15e59 years (64.4%) followed by the 0-to 4-year-old age group (13.4%) and persons $60 years (13.7%) ( Table 1 ). Severity increased with older age, with an inpatient fatality rate of 22.3% (95% CI: 16.5, 28.0) for persons $60 years.
The cumulative hospitalization and inpatient death rates for the three waves of the 2009e2010 A/H1N1 pandemic 
Geography
The majority of A/H1N1 inpatients during the fourth wave were reported in central Mexican states (55.1%) followed by southeastern states (27.9%) ( Table 1) , and a higher proportion of A/H1N1 deaths occurred in central states compared to other regions (c 2 test, p 5 0.04).
Estimates of the Reproduction Number
Assuming a mean generation interval of 3 (and 4) days, the mean R was estimated to be 1.2 (1.3) during the period from December 17, 2011eJanuary 9, 2012, based on daily A/H1N1-positive hospitalizations. As a sensitivity analysis
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Discussion
We characterized the epidemiology of a recrudescent fourth wave of A/H1N1 influenza transmission in Mexico spanning December 1, 2011eMarch 20, 2012, based on hospitalizations for severe acute respiratory infections and laboratoryconfirmed A/H1N1 infections. We compared the impact, severity, age patterns, and reproduction number of this fourth wave with those of earlier pandemic waves in spring, summer and fall 2009 in Mexico (1,4). We used individual-level patient information collected through a prospective influenza surveillance system put into place especially for the 2009 pandemic by the largest Mexican Social Security medical system and providing daily data during the period from 2009e2012 (18) . Our data show that the nationwide peak level of daily SARI hospitalizations in 2012 exceeded the peak of SARI hospitalizations observed during the major fall pandemic wave in 2009. We also documented a significant increase in the proportion of A/H1N1 hospitalizations and deaths among persons $60 years of age relative to the 2009 pandemic, and a significant reduction in the proportion of A/H1N1 hospitalizations and deaths among younger age groups.
The age shift seen in the 2011e2012 winter season most likely reflects a build-up of immunity among younger populations, a pattern similar to that reported among A/H1N1 hospitalized patients during the first post-pandemic season in Spain (17) . Yet, this epidemiological pattern may also be indicative of a gradual emergence of drift A/H1N1 variants. A recent study found that minor changes in the hemagglutinin of 2009 A/H1N1 influenza virus are sufficient to alter its antigenic properties (15) . Whether the observed age shift is due to a build-up of immunity or changes in the A/H1N1 influenza virus composition has implications for influenza prevention and mitigation strategies, which we discuss below.
The observed change in age distribution of hospitalization and deaths in the post-pandemic period of 2009 is reminiscent of the influenza seasons following the 1918 influenza pandemic (8, 9, 25) and the 1968 pandemic (26) , which highlights the importance of closely monitoring epidemiological and virological changes in the A/H1N1 influenza virus. A quantitative analysis of excess mortality prior to and after the1918 influenza pandemic found that the age distribution of influenza-related mortality returned to pre-pandemic mortality levels a few years after the initial pandemic waves as a result of emerging drift variants (9, 27) .
During the first year of circulation of the 2009 A/H1N1 influenza pandemic virus, protection from influenza-related morbidity and mortality rates was reported in persons O60 years of age. This phenomenon of senior sparing in age cohorts born prior to the 1957 pandemic is consistent with first exposure to antigenically related A/H1N1 viruses in childhood, a pattern consistent with the antigen recycling and original antigenic sin hypotheses (1,28e31) . A high fraction of the Mexican population is now protected against the 2009 A/H1N1 influenza virus through natural exposure in 2009 (children and young adults) or prior immunity (seniors) (7) and by pandemic vaccines. Over 8 million doses of seasonal influenza vaccine (featuring a good match for the H1N1-pdm vaccine component) were administered in 2011e2012 winter (35% vaccination coverage among IMSS-affiliated seniors $60 years of age, 70% among those !5 years of age, 40% among those 50e59 years of age, and 24% among those 5e9 years of age).
Although we saw evidence of a shift in the age distribution of 2011e2012 cases towards seniors, the absolute risk of being hospitalized was still relatively low in this age group, relative to those in younger adults. The declining rates of severe cases in younger age groups is most consistent with a build-up of immunity. Overall, the age distribution of the fourth wave of A/H1N1 influenza hospitalizations and deaths in Mexico is relatively flat and not quite back to the normal J-shaped age risk profile that characterizes seasonal influenza. In the long run, we expect the pandemic A/H1N1 virus to drift genetically to escape mounting population immunity-perhaps with the result that seniors are no longer protected (1) . Hence, the epidemiological evidence is consistent with the genetic and antigenic information published on circulating influenza virus, suggesting a lack of antigenic drift in A/H1N1 viruses in Mexico or elsewhere in winter 2011e2012, a season associated with relatively low A/H1N1 activity globally (32) .
Because transmission of the A/H1N1 influenza virus was sporadic in the winter of 2010e2011 in Mexico, we cannot rule out the possibility of some loss of population immunity since 2009. We estimated a reproduction number for the fourth A/H1N1 wave to be significantly lower to that of the spring (R |1.8e2.1) and summer (R |1.6e1.9) pandemic waves in 2009 in Mexico, but in close agreement with estimates of the fall (third) 2009 wave (R |1.2e1.3) (4).
Perhaps the most surprising finding of this analysis is the occurrence of a substantial fourth wave of pandemic A/H1N1 activity in Mexico, a country that has already experienced severe excess mortality impact during three waves of transmission in 2009 (4,6). Although we are just beginning to assess the global mortality burden of the 2009 A/H1N1 virus in the pandemic and post-pandemic period, important geographical variations in the number, timing, transmissibility and impact of sequential pandemic waves are obvious. For instance, the UK experienced two waves in spring and fall 2009, to be followed by a relatively severe recrudescent wave in 2010e2011 not seen in other European countries (33) . The U.S. experienced the brunt of the pandemic burden in the first year of A/H1N1 circulation. To our knowledge, the four-wave pattern seen in Mexico in 2009e2012 has not been reported in other countries. Whether these differences can be explained by geographical variations in prior immunity, seasonal drivers, control strategies, connectivity, health and healthcare is unclear and remains a key area for future research.
In summary, our findings indicate a changing age distribution of laboratory-confirmed A/H1N1 influenza hospitalizations and deaths in winter 2011e2012, relative to 2009e2010 A/H1N1 pandemic patterns. The proportion of hospitalizations and deaths is increasing in persons $60 years of age, an age group that was largely protected during the early pandemic waves in 2009. In contrast, rates of A/H1N1 hospitalizations and deaths are declining among younger population groups, consistent with a gradual buildup of immunity. This gradual change in the age distribution of A/H1N1 influenza in 2011e2012 in Mexico is reminiscent of post-pandemic patterns in past influenza pandemics. Nevertheless, the severity of the fourth wave was not different from the previous waves in terms of mortality. By contrast, during the 1889 pandemic, the third wave occurring in the winter of 1991e1992 was far more deadly than previous waves (14, 34) .
The dominant pattern of A/H1N1 influenza activity in winter 2011e2012 in Mexico is unique. By contrast, A/H3N2 influenza has driven winter epidemics in the U.S., Canada (together with influenza B viruses), Europe, North Africa and the Eastern Mediterranean Region, whereas influenza B transmission has predominated in China (35) . A multinational comparison of the epidemiology of pandemic and post-pandemic waves would be useful to shed light on the long-term transmission dynamics and build-up of immunity to pandemic viruses and report control strategies.
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